ID   UD14_HUMAN              Reviewed;         534 AA.
AC   P22310; B2R937; B8K288; Q5DT00;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=UDP-glucuronosyltransferase 1-4;
DE            Short=UDPGT 1-4;
DE            Short=UGT1*4;
DE            Short=UGT1-04;
DE            Short=UGT1.4;
DE            EC=2.4.1.17;
DE   AltName: Full=Bilirubin-specific UDPGT isozyme 2;
DE            Short=hUG-BR2;
DE   AltName: Full=UDP-glucuronosyltransferase 1-D;
DE            Short=UGT-1D;
DE            Short=UGT1D;
DE   AltName: Full=UDP-glucuronosyltransferase 1A4;
DE   Flags: Precursor;
GN   Name=UGT1A4; Synonyms=GNT1, UGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Liver;
RX   PubMed=1898728;
RA   Ritter J.K., Crawford J.M., Owens I.S.;
RT   "Cloning of two human liver bilirubin UDP-glucuronosyltransferase
RT   cDNAs with expression in COS-1 cells.";
RL   J. Biol. Chem. 266:1043-1047(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=1339448;
RA   Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T.,
RA   Owens I.S.;
RT   "A novel complex locus UGT1 encodes human bilirubin, phenol, and other
RT   UDP-glucuronosyltransferase isozymes with identical carboxyl
RT   termini.";
RL   J. Biol. Chem. 267:3257-3261(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11434514; DOI=10.1097/00008571-200106000-00011;
RA   Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K.,
RA   Kubota S., Carvalho S., Pennington M.W., Owens I.S., Popescu N.C.;
RT   "Thirteen UDP-glucuronosyltransferase genes are encoded at the human
RT   UGT1 gene complex locus.";
RL   Pharmacogenetics 11:357-368(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=14672974; DOI=10.1101/gr.1225204;
RA   Zhang T., Haws P., Wu Q.;
RT   "Multiple variable first exons: a mechanism for cell- and tissue-
RT   specific gene regulation.";
RL   Genome Res. 14:79-89(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-48.
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Guillemette C., Levesque E., Girard H., Bernard O.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INVOLVEMENT IN GILBS.
RX   PubMed=17496722; DOI=10.1097/FPC.0b013e328012d0da;
RA   Hsieh T.Y., Shiu T.Y., Huang S.M., Lin H.H., Lee T.C., Chen P.J.,
RA   Chu H.C., Chang W.K., Jeng K.S., Lai M.M., Chao Y.C.;
RT   "Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding
RT   protein binding affinity of UGT1A1 gene promoter.";
RL   Pharmacogenet. Genomics 17:229-236(2007).
RN   [11]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=18004212; DOI=10.1097/FPC.0b013e3282f1f118;
RA   Girard H., Levesque E., Bellemare J., Journault K., Caillier B.,
RA   Guillemette C.;
RT   "Genetic diversity at the UGT1 locus is amplified by a novel 3'
RT   alternative splicing mechanism leading to nine additional UGT1A
RT   proteins that act as regulators of glucuronidation activity.";
RL   Pharmacogenet. Genomics 17:1077-1089(2007).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-142 AND ASN-348.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   SUBUNIT.
RX   PubMed=20610558; DOI=10.1124/dmd.110.034835;
RA   Bellemare J., Rouleau M., Girard H., Harvey M., Guillemette C.;
RT   "Alternatively spliced products of the UGT1A gene interact with the
RT   enzymatically active proteins to inhibit glucuronosyltransferase
RT   activity in vitro.";
RL   Drug Metab. Dispos. 38:1785-1789(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT CN1 PHE-376.
RX   PubMed=1634050;
RA   Bosma P.J., Chowdhury J.R., Huang T.-J., Lahiri P., Elferink R.P.J.O.,
RA   van Es H.H.G., Lederstein M., Whitington P.F., Jansen P.L.M.,
RA   Chowdhury N.R.;
RT   "Mechanisms of inherited deficiencies of multiple UDP-
RT   glucuronosyltransferase isoforms in two patients with Crigler-Najjar
RT   syndrome, type I.";
RL   FASEB J. 6:2859-2863(1992).
RN   [16]
RP   VARIANTS CN2 PRO-132 AND ASP-487.
RX   PubMed=8280139; DOI=10.1006/bbrc.1993.2610;
RA   Aono S., Yamada Y., Keino H., Hanada N., Nakagawa T., Sasaoka Y.,
RA   Yazawa T., Sato H., Koiwai O.;
RT   "Identification of defect in the genes for bilirubin UDP-glucuronosyl-
RT   transferase in a patient with Crigler-Najjar syndrome type II.";
RL   Biochem. Biophys. Res. Commun. 197:1239-1244(1993).
RN   [17]
RP   VARIANT CN2 ARG-332.
RX   PubMed=8276413; DOI=10.1006/geno.1993.1451;
RA   Moghrabi N., Clarke D.J., Boxer M., Burchell B.;
RT   "Identification of an A-to-G missense mutation in exon 2 of the UGT1
RT   gene complex that causes Crigler-Najjar syndrome type 2.";
RL   Genomics 18:171-173(1993).
RN   [18]
RP   VARIANTS THR-24 AND VAL-48.
RX   PubMed=19204906; DOI=10.1002/humu.20946;
RA   Menard V., Girard H., Harvey M., Perusse L., Guillemette C.;
RT   "Analysis of inherited genetic variations at the UGT1 locus in the
RT   French-Canadian population.";
RL   Hum. Mutat. 30:677-687(2009).
CC   -!- FUNCTION: UDPGT is of major importance in the conjugation and
CC       subsequent elimination of potentially toxic xenobiotics and
CC       endogenous compounds. This isoform glucuronidates bilirubin IX-
CC       alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates
CC       and diconjugate. Isoform 2 lacks transferase activity but acts as
CC       a negative regulator of isoform 1 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor
CC       beta-D-glucuronoside.
CC   -!- SUBUNIT: Isoform 1 interacts with isoform 2/i2 suggesting that
CC       oligomerization is involved in negative regulation of transferase
CC       activity by isoform 2. Isoform 1 also interacts with respective i2
CC       isoforms of UGT1A1, UGT1A3, UGT1A6, UGT1A7, UGT1A8, UGT1A9 and
CC       UGT1A10. {ECO:0000269|PubMed:20610558}.
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=i1;
CC         IsoId=P22310-1; Sequence=Displayed;
CC       Name=2; Synonyms=i2, UGT1A4s;
CC         IsoId=P22310-2; Sequence=VSP_053960;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in
CC       liver, kidney, colon and small intestine. Isoform 2 but not
CC       isoform 1 is expressed in esophagus. Not expressed in skin.
CC       {ECO:0000269|PubMed:1339448, ECO:0000269|PubMed:18004212}.
CC   -!- INDUCTION: By phenobarbital.
CC   -!- DISEASE: Gilbert syndrome (GILBS) [MIM:143500]: Occurs as a
CC       consequence of reduced bilirubin transferase activity and is often
CC       detected in young adults with vague non-specific complaints.
CC       {ECO:0000269|PubMed:17496722}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Crigler-Najjar syndrome 1 (CN1) [MIM:218800]: Patients
CC       have severe hyperbilirubinemia and usually die of kernicterus
CC       (bilirubin accumulation in the basal ganglia and brainstem nuclei)
CC       within the first year of life. CN1 inheritance is autosomal
CC       recessive. {ECO:0000269|PubMed:1634050}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Crigler-Najjar syndrome 2 (CN2) [MIM:606785]: Patients
CC       have less severe hyperbilirubinemia and usually survive into
CC       adulthood without neurologic damage. Phenobarbital, which induces
CC       the partially deficient glucuronyl transferase, can diminish the
CC       jaundice. CN2 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:8276413, ECO:0000269|PubMed:8280139}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: The gene is part of the UGT1A complex locus which
CC       displays alternative use of promoters, first exons and terminal
CC       exons. The locus is defined by 13 first exons, which are
CC       alternatively spliced to 3 other common exons and 2 alternative
CC       terminal exons 5. From the 27 possible mRNA isoforms, 9 produce
CC       functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7,
CC       1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative
CC       exon 5 (5b) as terminal exon is leading to 9 additional
CC       alternatively spliced products termed isoforms i2 and which lack
CC       transferase activity.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84128; AAA61249.1; -; Genomic_DNA.
DR   EMBL; M84124; AAA61247.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M84122; AAA61247.1; JOINED; Genomic_DNA.
DR   EMBL; M84123; AAA61247.1; JOINED; Genomic_DNA.
DR   EMBL; M57951; AAA63196.1; -; mRNA.
DR   EMBL; AF297093; AAG30422.1; -; Genomic_DNA.
DR   EMBL; AY435139; AAR95640.1; -; mRNA.
DR   EMBL; AK313623; BAG36384.1; -; mRNA.
DR   EMBL; DQ364249; ABC96773.1; -; mRNA.
DR   EMBL; AC006985; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW71061.1; -; Genomic_DNA.
DR   EMBL; BC139784; AAI39785.1; -; mRNA.
DR   CCDS; CCDS33405.1; -. [P22310-1]
DR   RefSeq; NP_009051.1; NM_007120.2. [P22310-1]
DR   UniGene; Hs.554822; -.
DR   ProteinModelPortal; P22310; -.
DR   BioGrid; 120086; 1.
DR   IntAct; P22310; 9.
DR   STRING; 9606.ENSP00000362508; -.
DR   BindingDB; P22310; -.
DR   ChEMBL; CHEMBL3619; -.
DR   DrugBank; DB06216; Asenapine.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB00555; Lamotrigine.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB00910; Paricalcitol.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB00831; Trifluoperazine.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00313; Valproic Acid.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   iPTMnet; P22310; -.
DR   PhosphoSitePlus; P22310; -.
DR   BioMuta; UGT1A4; -.
DR   DMDM; 136731; -.
DR   PaxDb; P22310; -.
DR   PeptideAtlas; P22310; -.
DR   PRIDE; P22310; -.
DR   Ensembl; ENST00000373409; ENSP00000362508; ENSG00000244474. [P22310-1]
DR   Ensembl; ENST00000450233; ENSP00000408608; ENSG00000244474. [P22310-2]
DR   GeneID; 54657; -.
DR   KEGG; hsa:54657; -.
DR   UCSC; uc002vux.4; human. [P22310-1]
DR   CTD; 54657; -.
DR   DisGeNET; 54657; -.
DR   GeneCards; UGT1A4; -.
DR   HGNC; HGNC:12536; UGT1A4.
DR   MalaCards; UGT1A4; -.
DR   MIM; 143500; phenotype.
DR   MIM; 191740; gene.
DR   MIM; 218800; phenotype.
DR   MIM; 606429; gene.
DR   MIM; 606785; phenotype.
DR   neXtProt; NX_P22310; -.
DR   OpenTargets; ENSG00000244474; -.
DR   PharmGKB; PA37179; -.
DR   eggNOG; KOG1192; Eukaryota.
DR   eggNOG; COG1819; LUCA.
DR   GeneTree; ENSGT00760000118949; -.
DR   HOGENOM; HOG000220832; -.
DR   HOVERGEN; HBG004033; -.
DR   InParanoid; P22310; -.
DR   KO; K00699; -.
DR   OMA; ICHTFSA; -.
DR   OrthoDB; EOG091G06JC; -.
DR   PhylomeDB; P22310; -.
DR   TreeFam; TF315472; -.
DR   BioCyc; MetaCyc:HS11970-MONOMER; -.
DR   BRENDA; 2.4.1.17; 2681.
DR   Reactome; R-HSA-156588; Glucuronidation.
DR   Reactome; R-HSA-189483; Heme degradation.
DR   SABIO-RK; P22310; -.
DR   GeneWiki; UGT1A4; -.
DR   GenomeRNAi; 54657; -.
DR   PRO; PR:P22310; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000244474; -.
DR   Genevisible; P22310; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006789; P:bilirubin conjugation; TAS:Reactome.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:UniProtKB.
DR   GO; GO:0042167; P:heme catabolic process; TAS:Reactome.
DR   GO; GO:2001030; P:negative regulation of cellular glucuronidation; ISS:BHF-UCL.
DR   GO; GO:0045922; P:negative regulation of fatty acid metabolic process; ISS:BHF-UCL.
DR   GO; GO:1904224; P:negative regulation of glucuronosyltransferase activity; ISS:BHF-UCL.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; IBA:GO_Central.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   PANTHER; PTHR11926; PTHR11926; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Membrane;
KW   Microsome; Polymorphism; Reference proteome; Signal; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    534       UDP-glucuronosyltransferase 1-4.
FT                                /FTId=PRO_0000036003.
FT   TRANSMEM    492    508       Helical. {ECO:0000255}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    142    142       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    348    348       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ     436    534       SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLR
FT                                PAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRK
FT                                CLGKKGRVKKAHKSKTH -> RKKQQSGRQM (in
FT                                isoform 2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_053960.
FT   VARIANT      11     11       R -> W (in dbSNP:rs3892221).
FT                                /FTId=VAR_059844.
FT   VARIANT      24     24       P -> T (in dbSNP:rs6755571).
FT                                {ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_024684.
FT   VARIANT      48     48       L -> V (in dbSNP:rs2011425).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_058584.
FT   VARIANT      68     68       H -> Y (in dbSNP:rs45621441).
FT                                /FTId=VAR_061870.
FT   VARIANT     132    132       L -> P (in CN2; dbSNP:rs72551337).
FT                                {ECO:0000269|PubMed:8280139}.
FT                                /FTId=VAR_009506.
FT   VARIANT     176    176       I -> F (in dbSNP:rs45540231).
FT                                /FTId=VAR_052454.
FT   VARIANT     332    332       Q -> R (in CN2; dbSNP:rs72551348).
FT                                {ECO:0000269|PubMed:8276413}.
FT                                /FTId=VAR_007710.
FT   VARIANT     376    376       S -> F (in CN1; dbSNP:rs72551353).
FT                                {ECO:0000269|PubMed:1634050}.
FT                                /FTId=VAR_007711.
FT   VARIANT     487    487       Y -> D (in CN2; dbSNP:rs34993780).
FT                                {ECO:0000269|PubMed:8280139}.
FT                                /FTId=VAR_009507.
SQ   SEQUENCE   534 AA;  60025 MW;  AB745D46F57538BE CRC64;
     MARGLQVPLP RLATGLLLLL SVQPWAESGK VLVVPTDGSP WLSMREALRE LHARGHQAVV
     LTPEVNMHIK EEKFFTLTAY AVPWTQKEFD RVTLGYTQGF FETEHLLKRY SRSMAIMNNV
     SLALHRCCVE LLHNEALIRH LNATSFDVVL TDPVNLCGAV LAKYLSIPAV FFWRYIPCDL
     DFKGTQCPNP SSYIPKLLTT NSDHMTFLQR VKNMLYPLAL SYICHTFSAP YASLASELFQ
     REVSVVDLVS YASVWLFRGD FVMDYPRPIM PNMVFIGGIN CANGKPLSQE FEAYINASGE
     HGIVVFSLGS MVSEIPEKKA MAIADALGKI PQTVLWRYTG TRPSNLANNT ILVKWLPQND
     LLGHPMTRAF ITHAGSHGVY ESICNGVPMV MMPLFGDQMD NAKRMETKGA GVTLNVLEMT
     SEDLENALKA VINDKSYKEN IMRLSSLHKD RPVEPLDLAV FWVEFVMRHK GAPHLRPAAH
     DLTWYQYHSL DVIGFLLAVV LTVAFITFKC CAYGYRKCLG KKGRVKKAHK SKTH
//
